Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

IVT 25

Next Previous
Drug Profile

IVT 25

Alternative Names: 25-valent pneumococcal conjugate vaccine - Inventprise; IVT-25; IVT-25Valent PEGylated; IVT-PCV-25; IVT-Pneumo Conj. Vacc. -025; PCV25V

Latest Information Update: 05 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Inventprise
  • Class Conjugate vaccines; Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Pneumococcal infections
  • Preclinical Otitis media

Most Recent Events

  • 27 Jan 2025 Phase-II clinical trials in Pneumococcal infections (Prevention, In infants) in Philippines (IM) (NCT06790290)
  • 02 Jan 2024 Inventprise plans a phase II trial for pneumococcal infection (Prevention, In Infants) in mid 2024
  • 02 Jan 2024 Inventprise plans a phase II trial for pneumococcal infection (Prevention, In elderly) in second half of 2024

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top